"Global Genetic Testing Market Overview:
Global Genetic Testing Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Genetic Testing Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Genetic Testing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Genetic Testing Market:
The Genetic Testing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Genetic Testing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Genetic Testing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Genetic Testing market has been segmented into:
Carrier Testing
Diagnostic Testing
New-born Screening
Predictive and Presymptomatic Testing
Prenatal Testing
and Other Types
By Application, Genetic Testing market has been segmented into:
Alzheimer's Disease
Cancer
Cystic Fibrosis
Sickle Cell Anemia
Duchenne Muscular Dystrophy
Thalassemia
Huntington's Disease
Rare Diseases
and Other Diseases
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Genetic Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Genetic Testing market.
Top Key Players Covered in Genetic Testing market are:
23&Me Inc.
Qiagen NV
Eurofins Scientific
PerkinElmer Inc.
Illumina Inc.
Danaher Corporation
Myriad Genetics Inc.
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Quest Diagnostics Incorporated
BioRad Laboratories Inc.
DiaSorin S.p.A. (Luminex Corporation)
among others.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Genetic Testing Market by Type
4.1 Genetic Testing Market Snapshot and Growth Engine
4.2 Genetic Testing Market Overview
4.3 Carrier Testing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Carrier Testing: Geographic Segmentation Analysis
4.4 Diagnostic Testing
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Diagnostic Testing: Geographic Segmentation Analysis
4.5 New-born Screening
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 New-born Screening: Geographic Segmentation Analysis
4.6 Predictive and Presymptomatic Testing
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Predictive and Presymptomatic Testing: Geographic Segmentation Analysis
4.7 Prenatal Testing
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Prenatal Testing: Geographic Segmentation Analysis
4.8 and Other Types
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 and Other Types: Geographic Segmentation Analysis
Chapter 5: Genetic Testing Market by Application
5.1 Genetic Testing Market Snapshot and Growth Engine
5.2 Genetic Testing Market Overview
5.3 Alzheimer's Disease
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Alzheimer's Disease: Geographic Segmentation Analysis
5.4 Cancer
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Cancer: Geographic Segmentation Analysis
5.5 Cystic Fibrosis
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Cystic Fibrosis: Geographic Segmentation Analysis
5.6 Sickle Cell Anemia
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Sickle Cell Anemia: Geographic Segmentation Analysis
5.7 Duchenne Muscular Dystrophy
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Duchenne Muscular Dystrophy: Geographic Segmentation Analysis
5.8 Thalassemia
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Thalassemia: Geographic Segmentation Analysis
5.9 Huntington's Disease
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Huntington's Disease: Geographic Segmentation Analysis
5.10 Rare Diseases
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 Rare Diseases: Geographic Segmentation Analysis
5.11 and Other Diseases
5.11.1 Introduction and Market Overview
5.11.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.11.3 Key Market Trends, Growth Factors and Opportunities
5.11.4 and Other Diseases: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Genetic Testing Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 23&ME INC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 QIAGEN NV
6.4 EUROFINS SCIENTIFIC
6.5 PERKINELMER INC.
6.6 ILLUMINA INC.
6.7 DANAHER CORPORATION
6.8 MYRIAD GENETICS INC.
6.9 ABBOTT LABORATORIES
6.10 F. HOFFMANN-LA ROCHE LTD.
6.11 QUEST DIAGNOSTICS INCORPORATED
6.12 BIORAD LABORATORIES INC.
6.13 AND DIASORIN S.P.A. (LUMINEX CORPORATION)
6.14 AMONG OTHERS.
Chapter 7: Global Genetic Testing Market By Region
7.1 Overview
7.2. North America Genetic Testing Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Carrier Testing
7.2.4.2 Diagnostic Testing
7.2.4.3 New-born Screening
7.2.4.4 Predictive and Presymptomatic Testing
7.2.4.5 Prenatal Testing
7.2.4.6 and Other Types
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Alzheimer's Disease
7.2.5.2 Cancer
7.2.5.3 Cystic Fibrosis
7.2.5.4 Sickle Cell Anemia
7.2.5.5 Duchenne Muscular Dystrophy
7.2.5.6 Thalassemia
7.2.5.7 Huntington's Disease
7.2.5.8 Rare Diseases
7.2.5.9 and Other Diseases
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Genetic Testing Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Carrier Testing
7.3.4.2 Diagnostic Testing
7.3.4.3 New-born Screening
7.3.4.4 Predictive and Presymptomatic Testing
7.3.4.5 Prenatal Testing
7.3.4.6 and Other Types
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Alzheimer's Disease
7.3.5.2 Cancer
7.3.5.3 Cystic Fibrosis
7.3.5.4 Sickle Cell Anemia
7.3.5.5 Duchenne Muscular Dystrophy
7.3.5.6 Thalassemia
7.3.5.7 Huntington's Disease
7.3.5.8 Rare Diseases
7.3.5.9 and Other Diseases
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Genetic Testing Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Carrier Testing
7.4.4.2 Diagnostic Testing
7.4.4.3 New-born Screening
7.4.4.4 Predictive and Presymptomatic Testing
7.4.4.5 Prenatal Testing
7.4.4.6 and Other Types
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Alzheimer's Disease
7.4.5.2 Cancer
7.4.5.3 Cystic Fibrosis
7.4.5.4 Sickle Cell Anemia
7.4.5.5 Duchenne Muscular Dystrophy
7.4.5.6 Thalassemia
7.4.5.7 Huntington's Disease
7.4.5.8 Rare Diseases
7.4.5.9 and Other Diseases
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Genetic Testing Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Carrier Testing
7.5.4.2 Diagnostic Testing
7.5.4.3 New-born Screening
7.5.4.4 Predictive and Presymptomatic Testing
7.5.4.5 Prenatal Testing
7.5.4.6 and Other Types
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Alzheimer's Disease
7.5.5.2 Cancer
7.5.5.3 Cystic Fibrosis
7.5.5.4 Sickle Cell Anemia
7.5.5.5 Duchenne Muscular Dystrophy
7.5.5.6 Thalassemia
7.5.5.7 Huntington's Disease
7.5.5.8 Rare Diseases
7.5.5.9 and Other Diseases
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Genetic Testing Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Carrier Testing
7.6.4.2 Diagnostic Testing
7.6.4.3 New-born Screening
7.6.4.4 Predictive and Presymptomatic Testing
7.6.4.5 Prenatal Testing
7.6.4.6 and Other Types
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Alzheimer's Disease
7.6.5.2 Cancer
7.6.5.3 Cystic Fibrosis
7.6.5.4 Sickle Cell Anemia
7.6.5.5 Duchenne Muscular Dystrophy
7.6.5.6 Thalassemia
7.6.5.7 Huntington's Disease
7.6.5.8 Rare Diseases
7.6.5.9 and Other Diseases
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Genetic Testing Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Carrier Testing
7.7.4.2 Diagnostic Testing
7.7.4.3 New-born Screening
7.7.4.4 Predictive and Presymptomatic Testing
7.7.4.5 Prenatal Testing
7.7.4.6 and Other Types
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Alzheimer's Disease
7.7.5.2 Cancer
7.7.5.3 Cystic Fibrosis
7.7.5.4 Sickle Cell Anemia
7.7.5.5 Duchenne Muscular Dystrophy
7.7.5.6 Thalassemia
7.7.5.7 Huntington's Disease
7.7.5.8 Rare Diseases
7.7.5.9 and Other Diseases
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Genetic Testing Scope:
|
Report Data
|
Genetic Testing Market
|
|
Genetic Testing Market Size in 2025
|
USD XX million
|
|
Genetic Testing CAGR 2025 - 2032
|
XX%
|
|
Genetic Testing Base Year
|
2024
|
|
Genetic Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
23&Me Inc., Qiagen NV, Eurofins Scientific, PerkinElmer Inc., Illumina Inc., Danaher Corporation, Myriad Genetics Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Quest Diagnostics Incorporated, BioRad Laboratories Inc., and DiaSorin S.p.A. (Luminex Corporation), among others..
|
|
Key Segments
|
By Type
Carrier Testing
Diagnostic Testing
New-born Screening
Predictive and Presymptomatic Testing
Prenatal Testing
and Other Types
By Applications
Alzheimer's Disease
Cancer
Cystic Fibrosis
Sickle Cell Anemia
Duchenne Muscular Dystrophy
Thalassemia
Huntington's Disease
Rare Diseases
and Other Diseases
|
